theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Cardiovascular disease   

Questions discussed in this category


What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
1 Answer available

What is your approach to monitoring lipids in patients with rheumatic diseases such as RA and SLE and do you have a lower threshold to start lipid lowering agents compared to the general population?
2 Answers available
208768357


Papers discussed in this category


Southern medical journal, 2016-11
Effects of Statin Therapy in Patients with Systemic Lupus Erythematosus.

Annals of the rheumatic diseases, 2011-05
Lupus Atherosclerosis Prevention Study (LAPS).

Atherosclerosis, 2015 Aug 28
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.

N Engl J Med,
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

Autoimmunity reviews, 2023 Dec 20
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.

Related Topics

  • Primary Care
  • Rheumatology
  • General Rheumatology
  • Endocrinology
  • Lipid Disorders
  • Rheumatoid Arthritis
  • Systemic lupus erythematosus
  • JAK Inhibitors
  • Dermatology

Copyright © 2025 theMednet
All Rights Reserved.